FFCP PHASE1:Mm9::chr10:44184001..44184021,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=53|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr10:44184001..44184021,-|id=chr10:44184001..44184021,-|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0000970!5.76e-31!9;UBERON:0000019!5.76e-31!9;UBERON:0000047!5.76e-31!9;UBERON:0004088!5.76e-31!9;UBERON:0002104!5.76e-31!9;UBERON:0001456!5.76e-31!9;UBERON:0003072!5.76e-31!9;UBERON:0003071!5.76e-31!9;UBERON:0004128!5.76e-31!9;UBERON:0001444!2.06e-25!11;UBERON:0000020!2.50e-23!12;UBERON:0001032!2.50e-23!12;UBERON:0004456!2.50e-23!12;UBERON:0005085!1.46e-21!13|ontology_enrichment_uberon_v019_2=UBERON:0000970,1.98e-20,9;UBERON:0000019,1.98e-20,9;UBERON:0000047,1.98e-20,9;UBERON:0010312,1.98e-20,9;UBERON:0004088,1.98e-20,9;UBERON:0002104,1.98e-20,9;UBERON:0001456,1.98e-20,9;UBERON:0003072,1.98e-20,9;UBERON:0004128,1.98e-20,9;UBERON:0003071,1.98e-20,9;UBERON:0001444,5.67e-17,11;UBERON:0000020,1.13e-15,12;UBERON:0001032,1.13e-15,12;UBERON:0004456,1.13e-15,12;UBERON:0000033,1.42e-14,13;UBERON:0005085,1.42e-14,13|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.220868540951614,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.229902104433473,0,0.753524089178575,0.612328492361951,1.40925092313335,1.87403449119458,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.164698954724011,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.185194527369712,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr10:44184001..44184021,-}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=53 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr10:44184001..44184021,- | |||
|description=CAGE_peak_at_chr10:44184001..44184021,- | |||
|id=chr10:44184001..44184021,- | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0000970!5.76e-31!9;UBERON:0000019!5.76e-31!9;UBERON:0000047!5.76e-31!9;UBERON:0004088!5.76e-31!9;UBERON:0002104!5.76e-31!9;UBERON:0001456!5.76e-31!9;UBERON:0003072!5.76e-31!9;UBERON:0003071!5.76e-31!9;UBERON:0004128!5.76e-31!9;UBERON:0001444!2.06e-25!11;UBERON:0000020!2.50e-23!12;UBERON:0001032!2.50e-23!12;UBERON:0004456!2.50e-23!12;UBERON:0005085!1.46e-21!13 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0000970,1.98e-20,9;UBERON:0000019,1.98e-20,9;UBERON:0000047,1.98e-20,9;UBERON:0010312,1.98e-20,9;UBERON:0004088,1.98e-20,9;UBERON:0002104,1.98e-20,9;UBERON:0001456,1.98e-20,9;UBERON:0003072,1.98e-20,9;UBERON:0004128,1.98e-20,9;UBERON:0003071,1.98e-20,9;UBERON:0001444,5.67e-17,11;UBERON:0000020,1.13e-15,12;UBERON:0001032,1.13e-15,12;UBERON:0004456,1.13e-15,12;UBERON:0000033,1.42e-14,13;UBERON:0005085,1.42e-14,13 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.220868540951614,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.229902104433473,0,0.753524089178575,0.612328492361951,1.40925092313335,1.87403449119458,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.164698954724011,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.185194527369712,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr10:44184001..44184021,- | |||
}} |
Latest revision as of 10:07, 4 August 2015
Short description: | p@chr10:44184001..44184021, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr10:44184001..44184021, - |
Coexpression cluster: | MCL_coexpression_mm9:53 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
eye | 1.98e-20 | 9 |
camera-type eye | 1.98e-20 | 9 |
simple eye | 1.98e-20 | 9 |
immature eye | 1.98e-20 | 9 |
ocular region | 1.98e-20 | 9 |
visual system | 1.98e-20 | 9 |
face | 1.98e-20 | 9 |
optic cup | 1.98e-20 | 9 |
optic vesicle | 1.98e-20 | 9 |
eye primordium | 1.98e-20 | 9 |
subdivision of head | 5.67e-17 | 11 |
sense organ | 1.13e-15 | 12 |
sensory system | 1.13e-15 | 12 |
entire sense organ system | 1.13e-15 | 12 |
head | 1.42e-14 | 13 |
ectodermal placode | 1.42e-14 | 13 |